Evidence map›Paper›PMID 29244981›Full record

ArticleJournal of global oncology2017

Treatment, Not Terror: Time for Unique Problem-Solving Partnerships for Cancer Care in Resource-Challenged Environments.

C Norman Coleman, Miles A Pomper, Nelson Chao, Ferenc Dalnoki-Veress, David A Pistenmaa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of global oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

C Norman ColemanC. Norman Coleman, National Cancer Institute, Bethesda, MD; Miles A. Pomper and Ferenc Dalnoki-Veress, James Martin Center for Nonproliferation Studies, Washington, DC, and Monterey, CA; Nelson Chao, Duke Cancer Institute, Durham, NC; and David A. Pistenmaa, International Cancer Expert Corps, Washington, DC.
Miles A PomperC. Norman Coleman, National Cancer Institute, Bethesda, MD; Miles A. Pomper and Ferenc Dalnoki-Veress, James Martin Center for Nonproliferation Studies, Washington, DC, and Monterey, CA; Nelson Chao, Duke Cancer Institute, Durham, NC; and David A. Pistenmaa, International Cancer Expert Corps, Washington, DC.
Nelson ChaoC. Norman Coleman, National Cancer Institute, Bethesda, MD; Miles A. Pomper and Ferenc Dalnoki-Veress, James Martin Center for Nonproliferation Studies, Washington, DC, and Monterey, CA; Nelson Chao, Duke Cancer Institute, Durham, NC; and David A. Pistenmaa, International Cancer Expert Corps, Washington, DC.
Ferenc Dalnoki-VeressC. Norman Coleman, National Cancer Institute, Bethesda, MD; Miles A. Pomper and Ferenc Dalnoki-Veress, James Martin Center for Nonproliferation Studies, Washington, DC, and Monterey, CA; Nelson Chao, Duke Cancer Institute, Durham, NC; and David A. Pistenmaa, International Cancer Expert Corps, Washington, DC.
David A PistenmaaC. Norman Coleman, National Cancer Institute, Bethesda, MD; Miles A. Pomper and Ferenc Dalnoki-Veress, James Martin Center for Nonproliferation Studies, Washington, DC, and Monterey, CA; Nelson Chao, Duke Cancer Institute, Durham, NC; and David A. Pistenmaa, International Cancer Expert Corps, Washington, DC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

TerrorismHealth ResourcesHumansNeoplasmsNoncommunicable DiseasesProblem SolvingRadioisotopesRadioisotopes

Identifiers

PMID29244981
PMCPMC5735972

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.